These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3017202)

  • 1. Ability of monoclonal antibody to herpes simplex virus glycoprotein gB to promote healing of herpetic skin lesions in nude mice.
    Yamamoto M; Tang JL; Kumano Y; Mori R; Kino Y
    Antiviral Res; 1986 Jul; 6(4):223-31. PubMed ID: 3017202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive immunization of mice with monoclonal antibodies to glycoprotein gB of herpes simplex virus.
    Kino Y; Eto T; Ohtomo N; Hayashi Y; Yamamoto M; Mori R
    Microbiol Immunol; 1985; 29(2):143-9. PubMed ID: 2989659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activities of human monoclonal antibodies to herpes simplex virus.
    Fujinaga S; Sugano T; Matsumoto Y; Masuho Y; Mori R
    J Infect Dis; 1987 Jan; 155(1):45-53. PubMed ID: 3025308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combined use of acyclovir and antibody in athymic nude mice inoculated intracutaneously with herpes simplex virus.
    Yamamoto M; Hayashi Y; Tang LL; Mori R
    Antiviral Res; 1985 Apr; 5(2):83-91. PubMed ID: 2990334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissemination of herpes simplex virus in nude mice after intracutaneous inoculation and effect of antibody on the course of infection.
    Kino Y; Hayashi Y; Hayashida I; Mori R
    J Gen Virol; 1982 Dec; 63(2):475-9. PubMed ID: 6296289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against herpes simplex virus infection in mice by recombinant murine interferon-beta in combination with antibody.
    Kumano Y; Yamamoto M; Mori R
    Antiviral Res; 1987 Jun; 7(5):289-301. PubMed ID: 2821897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of purified glycoprotein gB of herpes simplex virus.
    Kino Y; Eto T; Nishiyama K; Ohtomo N; Mori R
    Arch Virol; 1986; 89(1-4):69-80. PubMed ID: 3013134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of herpes simplex virus in congenitally athymic mice: the relative roles of cell-mediated and humoral immunity.
    Kapoor AK; Nash AA; Wildy P; Phelan J; McLean CS; Field HJ
    J Gen Virol; 1982 Jun; 60(Pt 2):225-33. PubMed ID: 6286849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus type 1 infection in mice with severe combined immunodeficiency (SCID).
    Minagawa H; Sakuma S; Mohri S; Mori R; Watanabe T
    Arch Virol; 1988; 103(1-2):73-82. PubMed ID: 2850780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of immunization on acute and latent infections of vaginouterine tissue with herpes simplex virus types 1 and 2.
    Walz MA; Price RW; Hayashi K; Katz BJ; Notkins AL
    J Infect Dis; 1977 May; 135(5):744-52. PubMed ID: 192810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different mechanisms of protection by monoclonal and polyclonal antibodies during the course of herpes simplex virus infection.
    Eis-Hübinger AM; Mohr K; Schneweis KE
    Intervirology; 1991; 32(6):351-60. PubMed ID: 1657825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus.
    Forrester AJ; Sullivan V; Simmons A; Blacklaws BA; Smith GL; Nash AA; Minson AC
    J Gen Virol; 1991 Feb; 72 ( Pt 2)():369-75. PubMed ID: 1704412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
    J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes.
    Eis-Hübinger AM; Schmidt DS; Schneweis KE
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():379-85. PubMed ID: 8383173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
    Chan WL; Lukig ML; Liew FY
    J Exp Med; 1985 Oct; 162(4):1304-18. PubMed ID: 2995536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein gB of herpes simplex virus expresses type-common and type-specific antigenic determinants in vivo.
    Dix RD
    J Med Virol; 1990 Mar; 30(3):192-5. PubMed ID: 1692872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a type-common human recombinant monoclonal antibody to herpes simplex virus with high therapeutic potential.
    De Logu A; Williamson RA; Rozenshteyn R; Ramiro-Ibañez F; Simpson CD; Burton DR; Sanna PP
    J Clin Microbiol; 1998 Nov; 36(11):3198-204. PubMed ID: 9774565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL; Duncan BE; Raybould TJ; Watson DH
    J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.